Last update 19 Sep 2024
Convergent Therapeutics, Inc.

Convergent Therapeutics, Inc.

Startups
|
Holding Company|
2021|
Massachusetts, United States
|
< 10
|

Overview

Basic Info

Introduction
Convergent Therapeutics is a pharmaceutical company based in Cambridge, Massachusetts, that specializes in creating radiopharmaceutical therapies for prostate cancer. The company was established by Neil H. Bander and Philip Wayne Kantoff. Convergent Therapeutics is focused on developing next-generation radiopharmaceutical therapies for prostate and other cancers using proprietary dual-targeted radionuclide therapy developed by Dr. Neil Bander. The company's lead product, CONV 01-a, is a monoclonal antibody conjugated with 225Ac, a radioactive alpha particle emitter, designed to bind to the prostate-specific membrane antigen (PSMA).

Tags

Urogenital Diseases
Neoplasms
Therapeutic radiopharmaceuticals
Radiolabeled antibody

Disease domain score
A glimpse into the focused therapeutic areas
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
Disease DomainCount
Neoplasms2
Top 5 Drug TypeCount
Radiolabeled antibody2
Therapeutic radiopharmaceuticals2

Corporation Tree

Boost your research with our corporation tree data.
Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 05 Oct 2024

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
IND Approval
1
2
Phase 2 Clinical
Login to view more data

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Profit

Explore the financial positions of over 360K organizations with Synapse.
Explore the financial positions of over 360K organizations with Synapse.

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.
Access more than 2 million grant and funding information to elevate your research journey.

Investment

Gain insights on the latest company investments from start-ups to established corporations.
Gain insights on the latest company investments from start-ups to established corporations.

Financing

Unearth financing trends to validate and advance investment opportunities.
Unearth financing trends to validate and advance investment opportunities.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free